Hoth Therapeutics (HOTH), a New York-based biopharmaceutical company, announces IP advancements with expanded patent applications for its therapeutic pipeline.
The new patents highlight Hoth's dedication to developing innovative treatments, improving efficacy, and expanding applications for unmet medical needs.
The company invests in research and development to protect and grow its technologies, focusing on advancing its pipeline and delivering impactful healthcare solutions.
HOTH is currently trading at $1.3901 or 7.3267% lower on the Nasdaq Capital Market.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.